Gain of Distal Chromosome Arm 17q Is Not Associated with Poor Prognosis in Neuroblastoma

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4835-4840

  Spitz, Ruediger ^a   Hero, Barbara ^a   Ernestus, Karen ^a   Berthold, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME LOSS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA PROBE; EVALUATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCATION; GENETIC GAIN; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; OUTCOMES RESEARCH; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SURVIVAL RATE; TISSUE SECTION; TUMOR CELL;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; COHORT STUDIES; DNA; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0142157121     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Biedler, J., Ross, R. A., Shanske, S., and Spengler, B. A. Human neuroblastoma cytogenetics: search for significance of homogeneously staining regions and double minute chromosomes. Advances in Neuroblastoma Research, pp. 81-96. New York: Raven Press, 1980.
2. Gilbert, F., Feder, M., Balaban, G., Brangman, D., Lurie, D. K., Podolsky, R., Rinaldt, V., Vinikoor, N., and Weisband, J. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res., 44: 5444-5449. 1984.
3. Plantaz, D., Mohapatra, G., Matthay, K. K., Pellarin, M., Seeger, R. C., and Feuerstein, B. G. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am. J. Pathol., 150: 81-89, 1997.
4. Abel, F., Ejeskar, K., Kogner, P., and Martinsson, T. Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24. Br. J. Cancer, 81: 1402-1409, 1999.
5. Bown, N., Cotterill, S., Lastowska, M., O'Neill, S., Pearson, A. D., Plantaz, D., Meddeb, M., Danglot, G., Brinkschmidt, C., Christiansen, H., Laureys, G., and Speleman, F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N. Engl. J. Med., 340: 1954-1961, 1999.
6. Brinkschmidt, C., Christiansen, H., Terpe, H. J., Simon, R., Lampert, F., Boecker, W., and Dockhorn-Dworniczak, B. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med. Pediatr. Oncol., 36: 11-13, 2001.
7. Lastowska, M., Roberts, P., Pearson, A. D., Lewis, I., Wolstenholme, J., and Bown, N. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer, 19: 143-149, 1997.
8. Savelyeva, L., Corvi, R., and Schwab, M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am. J. Hum. Genet., 55: 334-340, 1994.
9. Van Roy, N., Laureys, G., Cheng, N. C., Willem, P., Opdenakker, G., Versteeg, R., and Speleman, F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer, 10: 103-114, 1994.
10. Van Roy, N., Cheng, N. C., Laureys, G., Opdenakker, G., Versteeg, R., and Speleman, F. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur. J. Cancer, 31: 530-535, 1995.
11. Lastowska, M., Van Roy, N., Bown, N., Speleman, F., Lunec, J., Strachan, T., Pearson, A. D., and Jackson, M, S. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer, 23: 116-122, 1998.
12. Lastowska, M., Cotterill, S., Bown, N., Cullinane, C., Variend, S., Lunec, J., Strachan, T., Pearson, A. D., and Jackson, M. S. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer, 34: 428-436, 2002.
13. Schilling, F. H., Spix, C., Berthold, F., Erttmann, R., Fehse, N., Hero, B., Klein, G., Sander, J., Schwarz, K., Treuner, J., Zorn, U., and Michaelis, J. Neuroblastoma screening at one year of age. N. Engl. J. Med., 346: 1047-1053, 2002.
14. Spitz, R., Hero, B., Westermann, F., Ernestus, K., Schwab, M., and Berthold, F. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer, 34: 299-305, 2002.
15. Spitz, R., Hero, B., Ernestus, K., and Berthold, F. Deletions in Chromosomes 3(p) and 11(q) are new prognostic markers in localized and 4s neuroblastoma. Clin. Cancer Res., 9: 52-58, 2003.
16. du Manoir, S., Schrock, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter, P., and Cremer, T. Quantitative analysis of comparative genomic hybridization. Cytometry, 19: 27-41, 1995.
17. Bown, N., Lastowska, M., Cotterill, S., O'Neill, S., Ellershaw, C., Roberts, P., Lewis, I., Pearson, A. D., U. K. Cancer Cytogenetics Group and the U. K. Children's Cancer Study Group. 17q gain in neuroblastoma predicts adverse clinical outcome. U. K. Cancer Cytogenetics Group and the U. K. Children's Cancer Study Group. Med. Pediatr. Oncol., 36: 14-19, 2001.
18. Lastowska, M., Cotterill, S., Pearson, A. D., Roberts, P., MeGuckin, A., Lewis, I., and Bown, N. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U. K. Children's Cancer Study Group and the U. K. Cancer Cytogenetics Group. Eur. J. Cancer, 33: 1627-1633, 1997.
19. Janoueix-Lerosey, I., Penther, D., Thioux, M., de Cremoux, P., Derre, J., Ambros, P., Vielh, P., Benard, J., Aurias, A., and Delattre, O. Molecular analysis of chromosome arm 17q gain in neuroblastoma. Genes Chromosomes Cancer, 28: 276-284, 2000.
20. Mora, J., Gerald, W. L., Qin, J., and Cheung, N. K. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma. Cancer (Phila.), 94: 2756-2765, 2002.
21. Consolo, C. L., Bicocche, M. P., Petti, A. R., and Tonini, G. P. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br. J. Cancer, 83: 1295-1300, 2000.
22. Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., and White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol., 19: 93-101, 1997.
23. Brodeur, G. M., and Castleberry, R. P. Neuroblastoma. In: P. A. Pizzo and D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology, 3rd Ed., pp. 761-789. Philadelphia: J. B. Lippincott Company, 1997.